Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms, according to an international study.

Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms, according to an international study involving the ...

Ultragenyx Pharmaceutical RARE reported new findings from an ongoing, pivotal study of its investigational ... Rare Pediatric Disease and Orphan Drug designations in the United States.

Several cardiovascular drugs are used for treatment ... The substantial and consistent beneficial effects of irbesartan across the various arterial end points analyzed in this study support the ...

It can occur with prescription or nonprescription drugs. It can also range from mild to severe. Substance use disorder, formerly known as “drug abuse,” develops when substance use interferes ...

How aggressive should antihypertensive therapy be, and which drugs should be used ... investigators compared irbesartan (an angiotensin-receptor blocker), amlodipine (a calcium-channel blocker ...

In agreement with previous observations, in this study, irbesartan reduces microalbuminuria in hypertensive type 2 diabetic patients. Moreover, it has been originally observed that an AT 1-RA ...

The study evaluates MRK’s pulmonary arterial hypertension (PAH) drug, Winrevair (sotatercept), for a more advanced version of the disease. This decision is based on strong efficacy data from ...

Next in the study, published in the journal Drug and Alcohol Dependence, were stimulants such as Adderall, Ritalin, and methamphetamine, with an average of 4.4 quit attempts, followed by alcohol ...

These models allow scientists to study the behavior of the drug and the cancer without relying solely on human trials. By speeding up the process, these simulations provide doctors with valuable ...

ITM-11, the drug that ITM says succeeded in the Phase 3 neuroendocrine cancer study, contains the isotope lutetium-177, which is packaged together with a compound that targets a protein known as the ...

Found, a tele­health start­up that treats obe­si­ty with med­ica­tion and lifestyle coach­ing, un­veiled new re­search show­ing tens of thou­sands of its pa­tients lost sig­nif­i ...